nitazoxanide has been researched along with quinazolines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katakura, K; Kido, Y; Kita, K; Matsumoto, J; Miyoshi, H; Nonaka, N; Oku, Y; Sakamoto, K; Shinjyo, N; Yagi, K; Yamamoto, N | 1 |
| Hussar, DA | 1 |
| Bessoff, K; Foderaro, JE; Huston, CD; Jumani, RS; Spangenberg, T; Ward, GE | 1 |
3 other study(ies) available for nitazoxanide and quinazolines
| Article | Year |
|---|---|
Anaerobic NADH-fumarate reductase system is predominant in the respiratory chain of Echinococcus multilocularis, providing a novel target for the chemotherapy of alveolar echinococcosis.
Topics: Anaerobiosis; Animals; Echinococcosis, Hepatic; Echinococcus multilocularis; Electron Transport; Enzyme Inhibitors; Mitochondria; Nitro Compounds; Oxidoreductases Acting on CH-CH Group Donors; Quinazolines; Rotenone; Thiazoles; Ubiquinone | 2008 |
New drugs 04, part 1.
Topics: Adalimumab; Alefacept; alpha-Galactosidase; Anisoles; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antioxidants; Antiprotozoal Agents; Antirheumatic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Drug Approval; Drug Therapy; Fabry Disease; Gefitinib; Humans; Iduronidase; Indoles; Isoenzymes; Lentigo; Lung Neoplasms; Migraine Disorders; Mucopolysaccharidosis I; Nitro Compounds; Patient Education as Topic; Propylamines; Psoriasis; Pyrrolidines; Quinazolines; Recombinant Fusion Proteins; Serotonin Receptor Agonists; Thiazoles; Tryptamines | 2004 |
Identification of Cryptosporidium parvum active chemical series by Repurposing the open access malaria box.
Topics: Antiprotozoal Agents; Cryptosporidium parvum; Drug Repositioning; Humans; Hydroxyquinolines; Nitro Compounds; Quinazolines; Thiazoles; Toxoplasma | 2014 |